A new drug, FLAV-27, targets epigenetic changes in Alzheimer’s. In preclinical studies, the drug reduced levels of ...
Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...
Morning Overview on MSN
Duke study: Nasal swab may detect Alzheimer’s changes before symptoms
A team linked to Duke University and the UNC Alzheimer’s Disease Research Center has found that a simple brush swab of the nasal lining can pick up molecular and immune cell changes tied to ...
Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2025 Earnings Call Transcript March 18, 2026 Sera Prognostics, Inc. beats earnings expectations. Reported EPS is $-0.15768, expectations were $-0.18897.
Colchester Gazette on MSN
Man running London Marathon to campaign for better coeliac disease diagnosis
Joe Reader is running the London Marathon to raise awareness for Coeliac UK and help fund crucial research which could lead to more diagnoses.
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Pennpetro Energy PLC - London-based developer of "strategic ...
Integrative health is no longer on the fringes; it’s actively redefining prevention, performance, and patient care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results